A multicenter, double-blind, parallel group, placebo controlled study of creatine in subjects with treated Parkinson's disease (PD) Long-term Study (LS-1)

Trial Profile

A multicenter, double-blind, parallel group, placebo controlled study of creatine in subjects with treated Parkinson's disease (PD) Long-term Study (LS-1)

Discontinued
Phase of Trial: Phase III

Latest Information Update: 06 Oct 2016

At a glance

  • Drugs Creatine monohydrate (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Oct 2013 Planned end date changed from 1 May 2015 to 1 Jun 2014 as reported by ClinicalTrials.gov.
    • 05 Oct 2013 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 04 Sep 2012 Planned end date changed from 1 Mar 2015 to 1 May 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top